Patient-Funded Trials: Opportunity or Liability?

Cell Stem Cell 17 (2):135-137 (2015)
  Copy   BIBTEX

Abstract

Patient-funded trials are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols

Other Versions

No versions found

Similar books and articles

Currents in Contemporary Ethics.Timothy Caulfield, Trudo Lemmens, Douglas Kinsella & Michael McDonald - 2004 - Journal of Law, Medicine and Ethics 32 (2):365-368.

Analytics

Added to PP
2015-10-16

Downloads
547 (#41,000)

6 months
124 (#50,093)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Alex John London
Carnegie Mellon University
Danielle M. Wenner
Carnegie Mellon University

References found in this work

Add more references